I sent my letter to the SEC yesterday, but my point was based on that $1.1M buy, he believes in the product and likes the results. I like Geert as much as I like Cassandra. They may be one in the same.
The company needs money to continue the enrollment. If you want to kill enrollment, tell the participating clinics you're out of money. Cel Sci knows the probability of an arbitration win and they've made that clear. Does that change the need for immediate money to continue enrollment? Nope. Good things to come.